2987 studies found for:    Open Studies | chemotherapy
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | chemotherapy
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction Chemotherapy
Condition: Pancreatic Cancer
Interventions: Drug: Induction chemotherapy with gemcitabine or FOLFIRINOX;   Radiation: Radiotherapy, 28 x 1.8 Gy;   Drug: Chemotherapy, gemcitabine;   Drug: Chemotherapy with gemcitabine or FOLFIRINOX according to induction chemotherapy
2 Unknown  Peri-operative Chemotherapy With ECX or XP in the Treatment of Advanced Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: Peri-operative chemotherapy of ECX;   Drug: Peri-operative chemotherapy of XP
3 Recruiting Outcomes in CRS/HIPEC as Initial Treatment of Ovarian, Fallopian Tube and Primary Peritoneal Cancer
Conditions: Stage III Ovarian Cancer;   Stage IV Ovarian Cancer;   Epithelial Ovarian Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Carcinoma;   Ovarian Carcinoma;   Fallopian Tube Carcinoma
Interventions: Procedure: Cytoreductive Surgery (CRS);   Drug: Systemic Chemotherapy;   Other: Questionnaire;   Procedure: Hyperthermic intraperitoneal chemotherapy;   Drug: Carboplatin;   Drug: Paclitaxel
4 Recruiting Trial of Neoadjuvant Chemotherapy in Locally Advanced Colon Cancer
Conditions: Colon Cancer;   Locally Advanced Malignant Neoplasm
Interventions: Other: Perioperative simplified FOLFOX-4 chemotherapy;   Other: Perioperative FOLFOX4+Cetuximab chemotherapy;   Other: Surgery followed by FOLFOX4 chemotherapy
5 Not yet recruiting The Value of Single-cycle TPF Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: One cycle TPF induction chemotherapy for NPC;   Drug: Three cycles TPF induction chemotherapy for NPC
6 Recruiting Safety Study Of Anakinra Combined With Chemotherapy And Dendritic Cell Vaccine to Treat Breast Cancer
Condition: Breast Cancer
Interventions: Biological: DC vaccination+Preop chemotherapy;   Biological: DC vaccination+Preop chemo+anakinra
7 Recruiting Induction Chemotherapy Followed By Chrono-chemotherapy Concurrent With IMRT Of Locally Advanced NPC Clinical Study
Condition: Nasopharyngeal Carcinoma
Interventions: Device: Chrono-chemotherapy pump:Melodie;   Device: Routine intravenous drip;   Drug: induction chemotherapy;   Drug: cisplatin chrono-chemotherapy;   Radiation: intensity-modulated radiation therapy;   Drug: cisplatin routine-chemotherapy
8 Recruiting Combination of Cisplatin Plus Gemcitabine Induction Chemotherapy and Intensity-modulated radiotherapyIntensity-modulated Radiotherapy With or Without Concurrent Cisplatin for NPC
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Inductive chemotherapy + concurrent cisplatin and IMRT;   Drug: Inductive chemotherapy + IMRT
9 Recruiting Icotinib in Combination With Chemotherapy Versus Chemotherapy Alone in Patients Progressed After Icotinib Treatment
Condition: Non-small Cell Lung Cancer
Interventions: Drug: Chemotherapy;   Drug: Icotinib+chemotherapy
10 Unknown  High-dose Chemotherapy With Autologous Stem Cell Rescue in Pediatric High-risk Brain Tumors
Condition: Brain Tumor
Intervention: Procedure: high-dose chemotherapy and autologous stem cell rescue
11 Recruiting Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: Ovarian Cancer;   Fallopian Tubes Cancer;   Peritoneal Cancer
Interventions: Procedure: Secondary Cytoreductive Surgery;   Drug: Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC);   Drug: platinum-based systemic chemotherapy postoperatively
12 Recruiting Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy
Conditions: Non Small Cell Lung Cancer;   Breast Cancer
Interventions: Drug: YPEG-rhG-CSF, 20μg/kg, single s.c. at 48hrs after chemotherapy for each experimental cycle;   Drug: YPEG-rhG-CSF, 30μg/kg, single s.c. at 48hrs after chemotherapy for each experimental cycle;   Drug: YPEG-rhG-CSF, 45μg/kg, single s.c. at 48hrs after chemotherapy for each experimental cycle;   Drug: PEG-rhG-CSF, 100μg/kg, single s.c. at 48hrs after chemotherapy for each experimental cycle
13 Recruiting NPC Staged N2-3M0:Adjuvant Chemotherapy or Just Observation After Concurrent Chemoradiation
Condition: Nasopharyngeal Carcinoma
Intervention: Drug: Adjuvant chemotherapy with paclitaxel and nedaplatin
14 Unknown  Continuation Electroconvulsive Therapy (C-ECT) for Relapse Prevention in Major Depression
Condition: Depression
Interventions: Device: Thrymatron System IV device (CONSOLIDATION ELECTROCONVUsLIVE THERAPY) plus PHARMACOTHERAPY;   Drug: PHARMACOTHERAPY
15 Recruiting Concurrent Cisplatin Chemoradiation With or Without Capecitabine as Adjuvant Chemotherapy in Local Advanced High Risk Nasopharyngeal Carcinoma: Phase II Randomized Control Clinical Trial
Condition: Local Advanced High Risk Nasopharyngeal Carcinoma
Interventions: Drug: IMRT combine with cisplatin concurrent chemotherapy;   Drug: IMRT combine with cisplatin concurrent chemotherapy plus capecitabine adjuvant chemotherapy
16 Recruiting Maintenance Chemotherapy Versus Consolidative Stereotactic Body Radiation Therapy (SBRT) Plus Maintenance Chemotherapy for Stage IV Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II Trial
Condition: Stage IV Non-Small Cell Lung Cancer
Interventions: Radiation: Stereotactic Body Radiation Therapy;   Drug: Maintenance chemotherapy
17 Recruiting Adjuvant Chemotherapy for High-risk Retinoblastoma After Enucleation
Condition: Retinoblastoma
Interventions: Drug: 3 cycles chemotherapy;   Drug: 6 cycles chemotherapy
18 Recruiting Partial Breast Irradiation With Concurrent Chemotherapy for Women With Breast Cancer
Conditions: Breast Cancer;   Adenocarcinoma of the Breast
Interventions: Radiation: PBI;   Other: PBI with chemotherapy
19 Recruiting GC Regimen Chemotherapy Plus CIK Cells for Metastatic Nasopharyngeal Carcinoma
Condition: Stage IV Nasopharyngeal Carcinoma
Interventions: Drug: GC chemotherapy plus CIK cells (Gemcitabine, Cisplatin, Autologous CIK cells);   Drug: GC chemotherapy (Gemcitabine, Cisplatin)
20 Recruiting The Role of Postoperative Cycles in the Perioperative Chemotherapy for Gastric Cancer
Condition: Gastric Cancer
Intervention: Drug: Postoperative Chemotherapy

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years